Elegen, the leader in next-generation cell-free DNA manufacturing, today announced the early access launch of ENFINIAtm IVT Ready DNA. An expansion of its ENFINIA platform, this new product is ...

Elegen launches Early Access for ENFINIA IVT Ready DNA, complete with a long poly(A) tail, delivered fast & ready for ...

Since its discovery in 2011, CRISPR-Cas 9 has revolutionized medicine. One of the companies at the forefront of this ...

As we continue to see sequencing technologies advance and provide a deeper understanding of gene therapy targets along with ...

Investors reacted negatively to the news. The company’s stock fell more than 16% yesterday. It’s also a setback in ...

Beam Therapeutics and Verve Therapeutics have each built their lead candidates on a technique billed as a safer alternative ...

Researchers describe a concentric supraparticle system that protects and delivers RNA therapeutics for gene silencing in ...

Stagnation is not an option in the pharma world today. The companies that are anticipating these changes will be leaders, and ...

The study by Li et al. provides fundamental findings supported by convincing evidence that they defined cellular reprogramming of androgen receptor in neuroendocrine prostate cancer (NEPC). The ...

Kytopen and Aldevron announce collaboration to expedite cell therapy manufacturing by combining their novel technologies. High transgene expression and improved safety profile of Aldveron's ...

Be Biopharma, Inc. ("Be Bio"), a clinical-stage company pioneering the discovery and development of engineered B Cell Medicines (BCMs), today announced that it will present at the American Society of ...